Detheux Michel
Insider CIK 1816196 · ITOS Chief Executive Officer, Director · VOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 14,185 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 444,815 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 94,336 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 50,128 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 52,700 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 185,000 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 17,544 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | U Tender | 2025-08-29 | 2025-08-29 | 153,903 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | U Tender | 2025-08-29 | 2025-08-29 | 94,027 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-10 | 2025-06-11 | 8,400 | — | $0 | 18,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-10 | 2025-06-11 | 94,027 | — | $0 | 3 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-10 | 2025-06-11 | 18,000 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-10 | 2025-06-11 | 43,883 | — | $0 | 94,030 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-11 | 43,883 | $10.02 | $439.7K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-10 | 2025-06-11 | 18,000 | $4.30 | $77.4K | 153,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-10 | 2025-06-11 | 94,027 | $4.30 | $404.3K | 94,027 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-11 | 8,400 | $10.02 | $84.2K | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-10 | 2025-06-11 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-10 | 2025-06-11 | 43,883 | $4.30 | $188.7K | 43,883 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-09 | 2025-06-11 | 43,882 | — | $0 | 137,913 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-09 | 2025-06-11 | 8,400 | — | $0 | 26,400 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 43,882 | $10.03 | $440.1K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-09 | 2025-06-11 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 8,400 | $10.03 | $84.3K | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-09 | 2025-06-11 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-06 | 43,882 | — | $0 | 181,795 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-06 | 8,400 | — | $0 | 34,800 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-06 | 2025-06-06 | 8,400 | $10.21 | $85.8K | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-06 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-06 | 2025-06-06 | 43,882 | $10.21 | $448.0K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-05 | 2025-06-06 | 43,882 | — | $0 | 225,677 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-05 | 2025-06-06 | 8,400 | — | $0 | 43,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-06 | 43,882 | $10.15 | $445.4K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-05 | 2025-06-06 | 43,882 | $4.30 | $188.7K | 43,882 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-06 | 8,400 | $10.15 | $85.3K | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-05 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-04 | 2025-06-06 | 8,400 | — | $0 | 51,600 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-04 | 2025-06-06 | 43,883 | — | $0 | 269,559 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-04 | 2025-06-06 | 43,883 | $10.10 | $443.2K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-04 | 2025-06-06 | 43,883 | $4.30 | $188.7K | 43,883 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-04 | 2025-06-06 | 8,400 | $10.10 | $84.8K | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-04 | 2025-06-06 | 8,400 | $4.30 | $36.1K | 144,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 459,000 | — | $0 | 459,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2025-03-07 | 2025-03-11 | 77,000 | — | $0 | 135,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2024-08-08 | 2024-08-09 | 442,800 | — | $0 | 442,800 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2024-08-08 | 2024-08-09 | 442,800 | — | $0 | 147,600 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 590,400 | — | $0 | 590,400 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2023-12-05 | 2023-12-07 | 30,000 | — | $0 | 58,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2023-03-09 | 2023-03-10 | 254,997 | — | $0 | 254,997 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2023-03-09 | 2023-03-10 | 254,997 | — | $0 | 91,003 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 346,000 | — | $0 | 346,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-04-18 | 2022-04-19 | 11,500 | — | $0 | 144,464 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-04-18 | 2022-04-19 | 11,467 | $31.87 | $365.5K | 26,296 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-04-18 | 2022-04-19 | 33 | $32.64 | $1.1K | 26,263 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-04-18 | 2022-04-19 | 11,500 | $4.23 | $48.6K | 37,763 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-22 | 2022-03-22 | 9,908 | $34.11 | $338.0K | 28,970 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-22 | 2022-03-22 | 1,159 | $35.22 | $40.8K | 27,811 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-22 | 2022-03-22 | 1,548 | $36.51 | $56.5K | 26,263 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-22 | 2022-03-22 | 5,822 | $33.44 | $194.7K | 38,878 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-14 | 352,500 | — | $0 | 352,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2022-03-11 | 2022-03-14 | 10,000 | — | $0 | 44,700 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-02-23 | 2022-02-24 | 13,956 | $34.30 | $478.7K | 35,244 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-02-23 | 2022-02-24 | 544 | $35.32 | $19.2K | 34,700 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-25 | 2022-01-26 | 4,412 | $36.21 | $159.8K | 49,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-25 | 2022-01-26 | 10,088 | $35.45 | $357.6K | 53,612 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-22 | 2021-12-22 | 1,663 | — | $0 | 60,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-22 | 2021-12-22 | 1,663 | $4.30 | $7.2K | 79,863 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-22 | 149 | $44.92 | $6.7K | 78,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-22 | 5,007 | $44.62 | $223.4K | 73,193 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-22 | 9,493 | $45.37 | $430.7K | 63,700 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-22 | 1,514 | $44.31 | $67.1K | 78,349 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 19,226 | — | $0 | 61,663 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-21 | 2021-12-22 | 13,646 | $44.15 | $602.5K | 83,780 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-21 | 2021-12-22 | 5,580 | $45.06 | $251.4K | 78,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 19,226 | $4.30 | $82.7K | 97,426 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-20 | 2021-12-22 | 9,111 | — | $0 | 80,889 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-20 | 2021-12-22 | 9,111 | $4.30 | $39.2K | 87,311 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-20 | 2021-12-22 | 9,111 | $43.94 | $400.3K | 78,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 313,442 | — | $0 | 90,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 185,000 | — | $0 | 155,964 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 313,442 | — | $0 | 313,442 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 106,200 | — | $0 | 106,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 106,200 | — | $0 | 37,800 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 776,600 | — | $0 | 776,600 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 776,600 | — | $0 | 258,824 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 52,700 | — | $0 | 52,700 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | G Gift deriv | 2021-12-02 | 2021-12-22 | 52,700 | — | $0 | 17,544 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 14,500 | $36.08 | $523.2K | 78,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-11-22 | 2021-11-24 | 16,263 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-11-22 | 2021-11-24 | 16,263 | $12.45 | $202.5K | 92,700 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-03 | 2021-11-03 | 6,085 | $28.89 | $175.8K | 76,437 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 14,391 | $28.42 | $409.0K | 82,522 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 81 | $28.00 | $2.3K | 96,913 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-21 | 2021-10-25 | 196 | $28.00 | $5.5K | 96,994 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-19 | 2021-10-19 | 201 | $28.00 | $5.6K | 97,190 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-19 | 1,635 | $28.01 | $45.8K | 97,391 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-24 | 2021-09-27 | 1,089 | $28.02 | $30.5K | 99,026 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 5,322 | $28.16 | $149.9K | 100,115 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 11,018 | $28.91 | $318.5K | 105,987 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 550 | $29.49 | $16.2K | 105,437 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 8,684 | $28.30 | $245.8K | 117,005 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-31 | 2021-08-31 | 4,093 | $28.12 | $115.1K | 125,689 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-30 | 2021-08-31 | 2,322 | $28.01 | $65.0K | 129,782 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-27 | 2021-08-31 | 8,248 | $28.17 | $232.3K | 132,104 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-25 | 2021-08-25 | 861 | $28.00 | $24.1K | 140,352 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-24 | 2021-08-25 | 225 | $28.26 | $6.4K | 141,213 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 7,499 | $28.06 | $210.4K | 141,438 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-06-14 | 2021-06-16 | 3,937 | $29.26 | $115.2K | 148,937 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-06-14 | 2021-06-16 | 25,063 | $28.38 | $711.3K | 152,874 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 144,000 | — | $0 | 144,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 1,035,424 | — | $0 | 0 | SEC↗ |